Article Text

Download PDFPDF
Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer
  1. Matthias Woenckhaus1,
  2. Lukas Bubendorf2,
  3. Peter Dalquen2,
  4. Julia Foerster1,
  5. Hagen Blaszyk3,
  6. Martina Mirlacher4,
  7. Markus Soler5,
  8. Wolfgang Dietmaier1,
  9. Guido Sauter4,
  10. Arndt Hartmann1,
  11. Peter J Wild4
  1. 1Institute of Pathology, University of Regensburg, Regensburg, Germany
  2. 2Institute of Pathology, University of Basel, Basel, Switzerland
  3. 3Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont, USA
  4. 4Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  5. 5Pulmonary Division, Department of Internal Medicine, University of Basel, Basel, Switzerland
  1. Correspondence to:
 Dr M Woenckhaus
 Institute of Pathology, University of Regensburg, Franz-Josef-Strauss-Allee 11, D-93053 Regensburg, Germany; matthias.woenckhaus{at}


Aim: To investigate whether nuclear and cytoplasmic Maspin expression is associated with distinct clinicopathological parameters and TP53 expression in a representative series of primary non-small cell lung cancer (NSCLC).

Methods: Tissue microarrays (n = 487) were used to immunohistochemically analyse expression of Maspin and TP53. Cytoplasmic and nuclear expression of Maspin was scored on the basis of the percentage of positive tumour cells. Univariate analysis of clinicopathological variables potentially affecting tumour-specific survival was performed.

Results: Immunohistochemical Maspin expression (nuclear and cytoplasmic) was informative in 72.3% (352/487) of cases. Cytoplasmic and nuclear Maspin immunoreactivity in ⩾10% of tumour cells was detected in 37.8% (133/352) and 65.3% (230/352) of informative cases, respectively. Nuclear and cytoplasmic Maspin staining was observed more frequently in primary squamous cell carcinomas than in other lung cancer types. Only nuclear Maspin immunoreactivity was significantly associated with positive TP53 staining. Cytoplasmic or nuclear Maspin expression was not associated with tumour-specific survival.

Conclusion: Maspin expression was found both in the nucleus and the cytoplasm of NSCLC, more frequently in squamous cell carcinomas. However, no association with tumour-specific survival could be demonstrated.

  • IHC, immunohistochemistry
  • NSCLC, non-small cell lung cancer
  • TMA, tissue microarray

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Published Online First 12 May 2006

  • Competing interests: None.